CD22 and B-cell acute lymphoblastic leukemia: The aim of this study was to assess the relationship between culture conditions, specifically culture pH, and the growth kinetics and properties of CD22 CAR T-cells used for the treatment of pediatric B-cell acute lymphoblastic leukemia.